FDA Inspection 621495 — Mark L. Brantly, M.D.
The FDA completed an inspection of Mark L. Brantly, M.D. on September 21, 2009 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 21, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Gainesville, FL (United States)
Additional Details
Clinical Investigator (CI)